Literature DB >> 27390286

Pilot Mouse Study of 1 mm Inner Diameter (ID) Vascular Graft Using Electrospun Poly(ester urea) Nanofibers.

Yaohua Gao1, Tai Yi2, Toshiharu Shinoka2, Yong Ung Lee2, Darrell H Reneker1, Christopher K Breuer2, Matthew L Becker3.   

Abstract

An off-the-shelf, small diameter tissue engineered vascular graft (TEVG) would be transformative to surgeons in multiple subspecialties. Herein, the results of a small diameter (ID ≈ 1 mm) vascular graft constructed from resorbable, amino acid-based poly(ester urea) (PEU) are reported. Electrospun PEU grafts of two different wall thicknesses (type A: 250 μm; type B: 350 μm) are implanted as abdominal infra-renal aortic grafts in a severe combined immune deficient/beige mouse model and evaluated for vessel remodeling over one year. Significantly, the small diameter TEVG does not rupture or lead to acute thrombogenic events during the intervals tested. The pilot TEVG in vivo shows long-term patency and extensive tissue remodeling with type A grafts. Extensive tissue remodeling in type A grafts leads to the development of well-circumscribed neovessels with an endothelial inner lining, a neointima containing smooth muscle cells. However, due to slow degradation of the PEU scaffold materials in vivo, the grafts remain after one year. The type B grafts, which have 350 μm thick walls, experience occlusion over the one year interval due to intimal hyperplasia. This study affords significant findings that will guide the design of future generations of small diameter vascular grafts.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  SCID/Bg mice; bioresorbable; electrospun scaffolds; poly(ester urea); small diameter TEVG

Mesh:

Substances:

Year:  2016        PMID: 27390286      PMCID: PMC5951289          DOI: 10.1002/adhm.201600400

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  57 in total

1.  Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model.

Authors:  Sarra de Valence; Jean-Christophe Tille; Damiano Mugnai; Wojciech Mrowczynski; Robert Gurny; Michael Möller; Beat H Walpoth
Journal:  Biomaterials       Date:  2011-09-21       Impact factor: 12.479

Review 2.  Vascular tissue engineering: from in vitro to in situ.

Authors:  Song Li; Debanti Sengupta; Shu Chien
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-10-22

3.  Small diameter electrospun silk fibroin vascular grafts: Mechanical properties, in vitro biodegradability, and in vivo biocompatibility.

Authors:  Valentina Catto; Silvia Farè; Irene Cattaneo; Marina Figliuzzi; Antonio Alessandrino; Giuliano Freddi; Andrea Remuzzi; Maria Cristina Tanzi
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-05-05       Impact factor: 7.328

4.  Effect of sustained heparin release from PCL/chitosan hybrid small-diameter vascular grafts on anti-thrombogenic property and endothelialization.

Authors:  Yao Yao; Jianing Wang; Yun Cui; Rong Xu; Zhihong Wang; Ju Zhang; Kai Wang; Yuejie Li; Qiang Zhao; Deling Kong
Journal:  Acta Biomater       Date:  2014-03-04       Impact factor: 8.947

5.  Polyhedral oligomeric silsequioxane-polyurethane nanocomposite microvessels for an artificial capillary bed.

Authors:  Ruben Y Kannan; Henryk J Salacinski; Mohan J Edirisinghe; George Hamilton; Alexander M Seifalian
Journal:  Biomaterials       Date:  2006-05-16       Impact factor: 12.479

6.  Hemocompatibility evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering.

Authors:  Delara Motlagh; Jian Yang; Karen Y Lui; Antonio R Webb; Guillermo A Ameer
Journal:  Biomaterials       Date:  2006-05-03       Impact factor: 12.479

7.  Microporous, complaint, biodegradable vascular grafts for the regeneration of the arterial wall in rat abdominal aorta.

Authors:  B van der Lei; H L Bartels; P Nieuwenhuis; C R Wildevuur
Journal:  Surgery       Date:  1985-11       Impact factor: 3.982

8.  Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft.

Authors:  Shuhei Tara; Hirotsugu Kurobe; Mark W Maxfield; Kevin A Rocco; Tai Yi; Yuji Naito; Christopher K Breuer; Toshiharu Shinoka
Journal:  J Vasc Surg       Date:  2014-04-16       Impact factor: 4.268

9.  Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery.

Authors:  Wei Wu; Robert A Allen; Yadong Wang
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

10.  Electrospun PGA/gelatin nanofibrous scaffolds and their potential application in vascular tissue engineering.

Authors:  Hadi Hajiali; Shapour Shahgasempour; M Reza Naimi-Jamal; Habibullah Peirovi
Journal:  Int J Nanomedicine       Date:  2011-09-27
View more
  5 in total

1.  Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.

Authors:  Takuma Fukunishi; Cameron A Best; Chin Siang Ong; Tyler Groehl; James Reinhardt; Tai Yi; Hideki Miyachi; Huaitao Zhang; Toshiharu Shinoka; Christopher K Breuer; Jed Johnson; Narutoshi Hibino
Journal:  Tissue Eng Part A       Date:  2017-06-13       Impact factor: 3.845

2.  Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response.

Authors:  Randall J Smith; Tai Yi; Bita Nasiri; Christopher K Breuer; Stelios T Andreadis
Journal:  FASEB J       Date:  2019-01-10       Impact factor: 5.191

Review 3.  Micro- and nanoscale biophysical cues for cardiovascular disease therapy.

Authors:  Priya Mohindra; Tejal A Desai
Journal:  Nanomedicine       Date:  2021-02-09       Impact factor: 6.096

4.  Mouse Model of Tracheal Replacement With Electrospun Nanofiber Scaffolds.

Authors:  Sayali Dharmadhikari; Cameron A Best; Nakesha King; Michaela Henderson; Jed Johnson; Christopher K Breuer; Tendy Chiang
Journal:  Ann Otol Rhinol Laryngol       Date:  2019-01-30       Impact factor: 1.547

5.  Endothelialization of arterial vascular grafts by circulating monocytes.

Authors:  Randall J Smith; Bita Nasiri; Julien Kann; Donald Yergeau; Jonathan E Bard; Daniel D Swartz; Stelios T Andreadis
Journal:  Nat Commun       Date:  2020-04-01       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.